Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1212/01.wnl.0000080363.10902.e9 | DOI Listing |
Cureus
December 2024
Department of Surgery, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, GBR.
Lower gastrointestinal bleeding (LGIB) is a common clinical condition typically associated with diseases like diverticular disease, inflammatory bowel disease, and cancer. However, rarer etiologies such as appendiceal hemorrhage can present similarly, complicating diagnosis and management. This case report discusses a 42-year-old male who presented with severe rectal bleeding.
View Article and Find Full Text PDFFront Cell Infect Microbiol
October 2024
School of Veterinary Medicine and Science, University of Nottingham, Nottingham, United Kingdom.
Introduction: is a member of the pyogenic cluster of commonly associated with intramammary infection and mastitis in dairy cattle. It is a poorly controlled globally endemic pathogen responsible for a significant cause of the disease worldwide. The ruminant mammary gland provides an atypical body niche in which immune cell surveillance occurs on both sides of the epithelial tissue.
View Article and Find Full Text PDFBiomedicines
July 2024
Center for Advanced Studies and Technology (CAST), University G. d'Annunzio of Chieti-Pescara, I-66100 Chieti, Italy.
Eur J Neurol
June 2024
Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, UK.
Background: Multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) show a high prevalence and rapid progression of dysphagia, which is associated with reduced survival. Despite this, the evidence base for gastrostomy is poor, and the optimal frequency and outcomes of this intervention are not known. We aimed to characterise the prevalence and outcomes of gastrostomy in patients with these three atypical parkinsonian disorders.
View Article and Find Full Text PDFJ Am Coll Cardiol
August 2023
Mount Sinai Medical Center, Miami Beach, Florida, USA.
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) leads. Device safety and efficacy were demonstrated previously with atypical clinical patients or limited follow-up.
Objectives: The S-ICD PAS (Subcutaneous Implantable Cardioverter-Defibrillator System Post Approval Study) is a real-world, multicenter, registry of U.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!